Showing results (341-350 of 440) with videos related to

Sort By:
Pageof 44
Thrombosis Research|February 1, 1990
Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenicity following injury: influence of salicylate and dipyridamole treatmentE Weber, T A Haas, T H Muller, et al.
Biophysical Journal|September 24, 1998
A new monofluorinated phosphatidylcholine forms interdigitated bilayersD J Hirsh, N Lazaro, L R Wright, et al.
Archives of Internal Medicine|January 10, 1994
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparinM N Levine, J Hirsh, M Gent, et al.
Thrombosis and Haemostasis|December 29, 2000
A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancyG Palareti, C Legnani, A Lee, et al.
The British Journal of Surgery|June 1, 1992
Prevention of venous thromboembolism after surgery: a review of enoxaparinD Bergqvist, G D Lowe, A Berstad, et al.
Thrombosis and Haemostasis|October 1, 1994
Effects on thrombin generation of single injections of Hirulog in patients with calf vein thrombosisJ S Ginsberg, M T Nurmohamed, M Gent, et al.
Archives of Internal Medicine|April 1, 1989
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hipP J Powers, M Gent, R M Jay, et al.
Circulation. Heart Failure|August 3, 2012
Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failureBenjamin J Hirsh, Andrea Mignatti, A Reshad Garan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1993
Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats. Lack of IL-6- and hepatocyte-dependent synthesisT J Podor, J Hirsh, T D Gelehrter, et al.
The Journal of Biological Chemistry|January 13, 2001
Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinaseJ A Anderson, J C Fredenburgh, A R Stafford, et al.
Pageof 44